Daniel Wildman

Board Member

Equibles does not estimate personal net worth.

About Daniel Wildman

Daniel Wildman is recorded as Board Member at UroGen Pharma Ltd. (URGN) since September 7, 2023. UroGen Pharma Ltd. reported in an 8-K filed September 11, 2023 that Daniel Wildman was appointed Director, effective September 7, 2023. UroGen Pharma Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at UroGen Pharma Ltd. includes Elizabeth Barrett (CEO and Board Member), Arie Belldegrun (Chairman and Board Member), Chris Degnan (CFO) and 7 others.

“The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”

UroGen Pharma Ltd. Form 8-K, filed September 11, 2023 · Read the filing

Affiliation history

UroGen Pharma Ltd. (URGN)
Board Member

Proxy statement

Current
2023-09-07–present

Company network

UroGen Pharma Ltd.

URGN

Current role

Biotechnology · Healthcare

Board Member

2023-09-07–present

Leadership on record at UroGen Pharma Ltd.

Elizabeth Barrett CEO, Board Member
Arie Belldegrun Chairman, Board Member
Chris Degnan CFO
Dong (Don) Kim CFO
Stephen L. Mullennix COO
Jason Smith General Counsel
Christopher Degnan Chief Accounting Officer
Arie Belldegrun, M.D. Board Member
Arie Belldegrun, M.D., FACS Board Member
Cynthia M. Butitta Board Member

Recent activity

Executive change Appointed: Director UroGen Pharma Ltd. (URGN)
2023-09-07